As litigation progresses, early cases could help shape future settlements and improve transparency in drug safety for all patients
"We know that, unfortunately, cardiovascular disease and chronic kidney disease just go hand in hand," Gough said
Fras JP, Auerbach P, Bajaj HS et al (2021) Efficacy and safety of once-weekly semaglutide 2.0 mg versus 1.0 mg in patients with type 2 diabetes (SUSTAIN FORTE): a double-blind, randomised, phase 3B trial
A prescription is needed because Semaglutide 7 mg tablets may cause side effects, drug interactions, or risks if used incorrectly
Many patients are surprised to learn that qualifying medical conditions can significantly influence eligibility and insurance approval